US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist

1.260
-0.020-1.56%

Close Nov 27 16:00 ET

1.290
+0.030+2.38%

Post 20:01 ET

145.17MMarket Cap-14000P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-14.21%-62.02M

253.50%59.73M

31.96%-46.77M

27.47%-174.88M

87.06%-12.94M

-46.40%-54.3M

22.23%-38.92M

-27.18%-68.73M

-544.17%-241.12M

-91.03%-99.95M

Net income from continuing operations

72.88%-10.75M

69.86%-12.92M

235.85%102.88M

18.46%-237.89M

-35.30%-79.65M

54.25%-39.64M

14.52%-42.87M

21.18%-75.73M

-1.62%-291.75M

-28.75%-58.87M

Operating gains losses

--1.09M

---11.46M

---153.65M

----

--6.22M

--0

Depreciation and amortization

72.30%1.55M

34.89%1.19M

58.80%1.51M

2.49%3.79M

1.24%1.06M

-9.65%899K

-0.79%880K

23.73%949K

7.09%3.7M

25.60%1.05M

Other non cash items

20.19%762K

434.43%1.43M

-1,989.15%-2.7M

-92.29%3.39M

123.18%3.31M

-60.13%634K

-126.74%-427K

-100.33%-129K

-69.27%43.96M

24.29%1.48M

Change In working capital

-122.77%-61.53M

1,292.23%74.26M

-21.74%-11.38M

53.54%-36.83M

111.66%6.37M

-417.69%-27.62M

61.60%-6.23M

45.40%-9.35M

-287.10%-79.26M

-165.00%-54.61M

-Change in receivables

110.37%7.81M

292.18%76.64M

0.59%8.58M

-1,254.48%-150.68M

-134.38%-44.06M

-406.97%-75.28M

-3,084.96%-39.88M

42.36%8.53M

-61.68%13.05M

-240.91%-18.8M

-Change in inventory

63.89%-6.94M

45.55%-7.1M

-328.87%-11.46M

1.30%-46.73M

-20.44%-11.79M

17.67%-19.23M

-16.04%-13.04M

9.82%-2.67M

-657.20%-47.35M

-6.56%-9.79M

-Change in prepaid assets

-116.92%-1.65M

-291.79%-2.24M

31.78%5.16M

203.08%18.18M

83.46%3.37M

149.25%9.72M

-84.72%1.17M

153.06%3.92M

-1,058.11%-17.64M

-69.11%1.84M

-Change in payables and accrued expense

-218.84%-67.93M

-77.32%10.33M

35.98%-12.24M

621.21%142.41M

311.21%58.85M

109.62%57.16M

425.95%45.53M

-49.84%-19.12M

-269.98%-27.32M

9.28%-27.86M

-Change in other working capital

--7.18M

---3.36M

---1.42M

----

Cash from discontinued investing activities

Operating cash flow

-14.21%-62.02M

253.50%59.73M

31.96%-46.77M

27.47%-174.88M

87.06%-12.94M

-46.40%-54.3M

22.23%-38.92M

-27.18%-68.73M

-544.17%-241.12M

-91.03%-99.95M

Investing cash flow

Cash flow from continuing investing activities

-99.12%444K

-33.14%27.66M

1,056.93%202.76M

186.69%144.64M

127.10%35.2M

11,160.39%50.55M

4,800.57%41.37M

149.21%17.53M

-20.55%-166.85M

-220.85%-129.9M

Net PPE purchase and sale

----

127.42%559K

----

-58.18%-2.04M

81.41%-87K

Net business purchase and sale

--0

----

--7M

--0

--7M

----

--0

Net investment purchase and sale

--0

-14.93%14.89M

208.44%138.14M

128.43%36.21M

--43.4M

--41.03M

--17.5M

-11,263.25%-127.38M

-217.99%-127.38M

Net other investing changes

194.04%444K

-58,972.65%-200.17M

722,496.15%187.88M

97.19%-1.05M

35.45%-1.57M

--151K

--340K

100.07%26K

72.48%-37.43M

---2.43M

Cash from discontinued investing activities

Investing cash flow

-99.12%444K

-33.14%27.66M

1,056.93%202.76M

186.69%144.64M

127.10%35.2M

11,160.39%50.55M

4,800.57%41.37M

149.21%17.53M

-20.55%-166.85M

-220.85%-129.9M

Financing cash flow

Cash flow from continuing financing activities

-101.50%-167K

-445.93%-187.93M

-76.68%887K

28.12%69.6M

-94.45%366K

-77.28%11.11M

7,434.67%54.33M

305.07%3.8M

4.72%54.33M

343.38%6.59M

Net issuance payments of debt

---141K

----

--0

----

--49.93M

--0

Net common stock issuance

--0

-100.10%-52K

-77.95%1.51M

1,028.00%71.72M

-101.65%-105K

--11.44M

--53.55M

--6.84M

-84.46%6.36M

--6.36M

Proceeds from stock option exercised by employees

--0

-49.30%685K

182.52%291K

-16.87%2.5M

37.38%996K

-32.91%53K

-18.76%1.35M

-81.07%103K

-77.53%3.01M

-57.10%725K

Net other financing activities

93.25%-26K

6,115.42%34.71M

70.93%-911K

7.06%-4.62M

-7.14%-525K

45.08%-385K

38.75%-577K

-10.39%-3.13M

-105.03%-4.97M

-141.38%-490K

Cash from discontinued financing activities

Financing cash flow

-101.50%-167K

-445.93%-187.93M

-76.68%887K

28.12%69.6M

-94.45%366K

-77.28%11.11M

7,434.67%54.33M

305.07%3.8M

4.72%54.33M

343.38%6.59M

Net cash flow

Beginning cash position

117.68%159.69M

1,469.05%260.23M

61.51%103.34M

-84.68%63.99M

-71.90%80.71M

-73.41%73.36M

-94.91%16.59M

-84.68%63.99M

-22.89%417.64M

-20.43%287.25M

Current changes in cash

-939.87%-61.74M

-277.08%-100.54M

430.96%156.88M

111.13%39.36M

110.14%22.63M

-35.07%7.35M

213.11%56.78M

48.20%-47.4M

-185.29%-353.65M

-494.07%-223.26M

End cash Position

21.36%97.95M

117.68%159.69M

1,469.05%260.23M

61.51%103.34M

-71.90%80.71M

-73.41%73.36M

-94.91%16.59M

-84.68%63.99M

Free cash flow

-14.21%-62.02M

253.50%59.73M

31.96%-46.77M

27.96%-175.17M

86.78%-13.22M

-44.62%-54.3M

23.57%-38.92M

-25.74%-68.73M

-527.99%-243.16M

-89.51%-100.04M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-14.21%-62.02M	253.50%59.73M	31.96%-46.77M	27.47%-174.88M	87.06%-12.94M	-46.40%-54.3M	22.23%-38.92M	-27.18%-68.73M	-544.17%-241.12M	-91.03%-99.95M
Net income from continuing operations	72.88%-10.75M	69.86%-12.92M	235.85%102.88M	18.46%-237.89M	-35.30%-79.65M	54.25%-39.64M	14.52%-42.87M	21.18%-75.73M	-1.62%-291.75M	-28.75%-58.87M
Operating gains losses	--1.09M	---11.46M	---153.65M	----	----	----	----	----	--6.22M	--0
Depreciation and amortization	72.30%1.55M	34.89%1.19M	58.80%1.51M	2.49%3.79M	1.24%1.06M	-9.65%899K	-0.79%880K	23.73%949K	7.09%3.7M	25.60%1.05M
Other non cash items	20.19%762K	434.43%1.43M	-1,989.15%-2.7M	-92.29%3.39M	123.18%3.31M	-60.13%634K	-126.74%-427K	-100.33%-129K	-69.27%43.96M	24.29%1.48M
Change In working capital	-122.77%-61.53M	1,292.23%74.26M	-21.74%-11.38M	53.54%-36.83M	111.66%6.37M	-417.69%-27.62M	61.60%-6.23M	45.40%-9.35M	-287.10%-79.26M	-165.00%-54.61M
-Change in receivables	110.37%7.81M	292.18%76.64M	0.59%8.58M	-1,254.48%-150.68M	-134.38%-44.06M	-406.97%-75.28M	-3,084.96%-39.88M	42.36%8.53M	-61.68%13.05M	-240.91%-18.8M
-Change in inventory	63.89%-6.94M	45.55%-7.1M	-328.87%-11.46M	1.30%-46.73M	-20.44%-11.79M	17.67%-19.23M	-16.04%-13.04M	9.82%-2.67M	-657.20%-47.35M	-6.56%-9.79M
-Change in prepaid assets	-116.92%-1.65M	-291.79%-2.24M	31.78%5.16M	203.08%18.18M	83.46%3.37M	149.25%9.72M	-84.72%1.17M	153.06%3.92M	-1,058.11%-17.64M	-69.11%1.84M
-Change in payables and accrued expense	-218.84%-67.93M	-77.32%10.33M	35.98%-12.24M	621.21%142.41M	311.21%58.85M	109.62%57.16M	425.95%45.53M	-49.84%-19.12M	-269.98%-27.32M	9.28%-27.86M
-Change in other working capital	--7.18M	---3.36M	---1.42M	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-14.21%-62.02M	253.50%59.73M	31.96%-46.77M	27.47%-174.88M	87.06%-12.94M	-46.40%-54.3M	22.23%-38.92M	-27.18%-68.73M	-544.17%-241.12M	-91.03%-99.95M
Investing cash flow
Cash flow from continuing investing activities	-99.12%444K	-33.14%27.66M	1,056.93%202.76M	186.69%144.64M	127.10%35.2M	11,160.39%50.55M	4,800.57%41.37M	149.21%17.53M	-20.55%-166.85M	-220.85%-129.9M
Net PPE purchase and sale	----	----	----	127.42%559K	----	----	----	----	-58.18%-2.04M	81.41%-87K
Net business purchase and sale	--0	----	----	--7M	--0	--7M	----	----	--0	--0
Net investment purchase and sale	--0	--0	-14.93%14.89M	208.44%138.14M	128.43%36.21M	--43.4M	--41.03M	--17.5M	-11,263.25%-127.38M	-217.99%-127.38M
Net other investing changes	194.04%444K	-58,972.65%-200.17M	722,496.15%187.88M	97.19%-1.05M	35.45%-1.57M	--151K	--340K	100.07%26K	72.48%-37.43M	---2.43M
Cash from discontinued investing activities
Investing cash flow	-99.12%444K	-33.14%27.66M	1,056.93%202.76M	186.69%144.64M	127.10%35.2M	11,160.39%50.55M	4,800.57%41.37M	149.21%17.53M	-20.55%-166.85M	-220.85%-129.9M
Financing cash flow
Cash flow from continuing financing activities	-101.50%-167K	-445.93%-187.93M	-76.68%887K	28.12%69.6M	-94.45%366K	-77.28%11.11M	7,434.67%54.33M	305.07%3.8M	4.72%54.33M	343.38%6.59M
Net issuance payments of debt	---141K	----	----	--0	--0	--0	----	----	--49.93M	--0
Net common stock issuance	--0	-100.10%-52K	-77.95%1.51M	1,028.00%71.72M	-101.65%-105K	--11.44M	--53.55M	--6.84M	-84.46%6.36M	--6.36M
Proceeds from stock option exercised by employees	--0	-49.30%685K	182.52%291K	-16.87%2.5M	37.38%996K	-32.91%53K	-18.76%1.35M	-81.07%103K	-77.53%3.01M	-57.10%725K
Net other financing activities	93.25%-26K	6,115.42%34.71M	70.93%-911K	7.06%-4.62M	-7.14%-525K	45.08%-385K	38.75%-577K	-10.39%-3.13M	-105.03%-4.97M	-141.38%-490K
Cash from discontinued financing activities
Financing cash flow	-101.50%-167K	-445.93%-187.93M	-76.68%887K	28.12%69.6M	-94.45%366K	-77.28%11.11M	7,434.67%54.33M	305.07%3.8M	4.72%54.33M	343.38%6.59M
Net cash flow
Beginning cash position	117.68%159.69M	1,469.05%260.23M	61.51%103.34M	-84.68%63.99M	-71.90%80.71M	-73.41%73.36M	-94.91%16.59M	-84.68%63.99M	-22.89%417.64M	-20.43%287.25M
Current changes in cash	-939.87%-61.74M	-277.08%-100.54M	430.96%156.88M	111.13%39.36M	110.14%22.63M	-35.07%7.35M	213.11%56.78M	48.20%-47.4M	-185.29%-353.65M	-494.07%-223.26M
End cash Position	21.36%97.95M	117.68%159.69M	1,469.05%260.23M	61.51%103.34M	61.51%103.34M	-71.90%80.71M	-73.41%73.36M	-94.91%16.59M	-84.68%63.99M	-84.68%63.99M
Free cash flow	-14.21%-62.02M	253.50%59.73M	31.96%-46.77M	27.96%-175.17M	86.78%-13.22M	-44.62%-54.3M	23.57%-38.92M	-25.74%-68.73M	-527.99%-243.16M	-89.51%-100.04M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data